Loss of miR-101-3p Promotes Transmigration of Metastatic Breast Cancer Cells through the Brain Endothelium by Inducing COX-2/MMP1 Signaling
Open Access
- 6 July 2020
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 13 (7), 144
- https://doi.org/10.3390/ph13070144
Abstract
Brain metastases represent one of the incurable end stages in breast cancer (BC). Developing effective or preventive treatments is hampered by a lack of knowledge on the molecular mechanisms driving brain metastasis. Transmigration of BC cells through the brain endothelium is a key event in the pathogenesis of brain metastasis. In this study, we identified miR-101-3p as a critical micro-RNA able to reduce transmigration of BC cells through the brain endothelium. Our results revealed that miR-101-3p expression is downregulated in brain metastatic BC cells compared to less invasive variants, and varies inversely compared to the brain metastatic propensity of BC cells. Using a loss-and-gain of function approach, we found that miR-101-3p downregulation increased transmigration of BC cells through the brain endothelium in vitro by inducing COX-2 expression in cancer cells, whereas ectopic restoration of miR-101-3p exerted a metastasis-reducing effect. In regulatory experiments, we found that miR-101-3p mediated its effect by modulating COX-2-MMP1 signaling capable of degrading the inter-endothelial junctions (claudin-5 and VE-cadherin), key components of the brain endothelium. These findings suggest that miR-101-3p plays a critical role in the transmigration of breast cancer cells through the brain endothelium by modulating the COX-2-MMP1 signaling and thus may serve as a therapeutic target that can be exploited to prevent or suppress brain metastasis in human breast cancer.Funding Information
- Terry Fox Foundation (I1032)
This publication has 53 references indexed in Scilit:
- The hCMEC/D3 cell line as a model of the human blood brain barrierFluids and Barriers of the CNS, 2013
- Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in VivoCancer Cell International, 2012
- Enforced Expression of miR-101 Inhibits Prostate Cancer Cell Growth by Modulating the COX-2 Pathway In VivoCancer Prevention Research, 2011
- The biology of brain metastases—translation to new therapiesNature Reviews Clinical Oncology, 2011
- MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting HeparanaseCancer Research, 2011
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cellsExperimental Cell Research, 2009
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- MicroRNA regulation of cyclooxygenase-2 during embryo implantationProceedings of the National Academy of Sciences of the United States of America, 2007
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004